QVR’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$48.5K 175
2025
Q3
$48.5K Buy
+100
New +$46.5K 0.01% 112
2023
Q1
Sell
-400
Closed -$220K 166
2022
Q4
$220K Sell
400
-3,000
-88% -$1.59M 0.03% 106
2022
Q3
$1.73M Sell
3,400
-4,500
-57% -$2.52M 0.14% 122
2022
Q2
$4.29M Sell
7,900
-9,900
-56% -$5.45M 0.31% 36
2022
Q1
$10.5M Buy
+17,800
New +$10.2M 0.4% 42
2021
Q4
Sell
-3,700
Closed -$2.11M 279
2021
Q3
$2.11M Buy
3,700
+500
+16% +$274K 0.14% 116
2021
Q2
$1.61M Buy
3,200
+2,400
+300% +$1.13M 0.16% 69
2021
Q1
$365K Buy
800
+300
+60% +$143K 0.03% 78
2020
Q4
$234K Buy
+500
New +$234K 0.02% 53

Other funds holding TMO

QVR's TMO Position: Q1 2026 in Review

QVR sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 848 shares — an estimated $460K sold.

QVR first reported a position in TMO in Q4 2020 and held it in 7 quarters. The position peaked at $491K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • QVR reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • QVR sold 848 Thermo Fisher Scientific shares in Q1 2026, an estimated $460K.
  • QVR first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 7 quarters.
  • QVR's Thermo Fisher Scientific position peaked at $491K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on QVR's 13F filing for Q1 2026, filed 15 Apr 2026.